Mutations in the BRCA2 gene have been implicated in pancreatic cancer susceptibility [73, 74], whereas the knockdown of LYN reduced human pancreatic cancer cell proliferation, migration, and invasion [75]. Here, LYN is linked to familial pancreatic carcinoma.